Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: an overview.

PubWeight™: 1.17‹?› | Rank: Top 10%

🔗 View Article (PMID 23370482)

Published in Mutat Res on January 28, 2013

Authors

Ajay Kumar Chaudhary1, Shruti Pandya, Kanjaksha Ghosh, Anita Nadkarni

Author Affiliations

1: Department of Haematogenetics, National Institute of Immunohaematology (NIIH), Indian Council of Medical Research (ICMR), King Edward Memorial (KEM) Hospital Campus, 13th Floor, NMS Bldg., Parel, Mumbai 400 012, India. Electronic address: ajaygenome@gmail.com.

Articles citing this

Cell-matrix interactions: focus on proteoglycan-proteinase interplay and pharmacological targeting in cancer. FEBS J (2014) 0.92

Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors. Cancer Biol Ther (2013) 0.85

Review on the Applications and Molecular Mechanisms of Xihuang Pill in Tumor Treatment. Evid Based Complement Alternat Med (2015) 0.81

Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: a meta-analysis. PLoS One (2015) 0.79

Targeting CD13 (aminopeptidase-N) in turn downregulates ADAM17 by internalization in acute myeloid leukaemia cells. Oncotarget (2014) 0.78

Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis. Oncotarget (2016) 0.78

Matrix metalloproteinase 13-containing exosomes promote nasopharyngeal carcinoma metastasis. Cancer Sci (2015) 0.78

Effect of Cnidii Rhizoma on nitric oxide production and invasion of human colorectal adenocarcinoma HT-29 cells. Oncol Lett (2014) 0.77

Cullin1 is up-regulated and associated with poor patients' survival in hepatocellular carcinoma. Int J Clin Exp Pathol (2015) 0.77

The Importance of Caveolin-1 as Key-Regulator of Three-Dimensional Growth in Thyroid Cancer Cells Cultured under Real and Simulated Microgravity Conditions. Int J Mol Sci (2015) 0.77

Andrographis paniculata elicits anti-invasion activities by suppressing TM4SF3 gene expression and by anoikis-sensitization in esophageal cancer cells. Am J Cancer Res (2015) 0.76

The progress of angiogenic factors in the development of leukemias. Intractable Rare Dis Res (2016) 0.76

Baicalein inhibits the migration and invasion of colorectal cancer cells via suppression of the AKT signaling pathway. Oncol Lett (2015) 0.76

Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome. World J Gastroenterol (2014) 0.75

Considering Rotatability of Hydroxyl Groups for the Active Site Residues of MMP-13 in Retrospective Virtual Screening Campaigns. Open Med Chem J (2016) 0.75

Association of MMP-2 (-1306 C>T), MMP-9 (-1562 C>T) Gene Polymorphism and the Formation of the Hematological Malignancies. Iran J Public Health (2016) 0.75

Prognostic Significance of Preoperative and Postoperative Plasma Levels of Ghrelin in Gastric Cancer: 3-Year Survival Study. Clin Transl Gastroenterol (2017) 0.75

Cancer and embryo expression protein 65 promotes cancer cell growth and metastasis. Oncol Lett (2015) 0.75

Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth. Mol Med Rep (2015) 0.75

Cullin1 is a novel prognostic marker and regulates the cell proliferation and metastasis in colorectal cancer. J Cancer Res Clin Oncol (2015) 0.75

Role of matrix metalloproteinase-9 in transforming growth factor-β1-induced epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Onco Targets Ther (2017) 0.75

Articles by these authors

A cross-sectional study evaluating chemiluminescence and autofluorescence in the detection of clinically innocuous precancerous and cancerous oral lesions. J Am Dent Assoc (2010) 2.46

Epidemiology of beta-thalassaemia in Western India: mapping the frequencies and mutations in sub-regions of Maharashtra and Gujarat. Br J Haematol (2010) 2.12

Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options. Autoimmun Rev (2010) 1.90

Hereditary thrombophilia in cerebral venous thrombosis: a study from India. Blood Coagul Fibrinolysis (2013) 1.66

Combination of thrombophilia markers in acute myocardial infarction of the young. Indian J Med Sci (2004) 1.52

Efficacy of fixed low dose hydroxyurea in Indian children with sickle cell anemia: a single centre experience. Indian Pediatr (2013) 1.44

Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype. Blood Cells Mol Dis (2008) 1.43

Prevalence and spectrum of von Willebrand disease from western India. Indian J Med Res (2005) 1.43

Antihistone and other autoantibodies in beta-thalassemia major patients receiving iron chelators. Acta Haematol (2003) 1.40

Mitochondrial DNA variations in myelodysplastic syndrome. Ann Hematol (2013) 1.39

Role of functional polymorphism of matrix metalloproteinase-2 (-1306 C/T and -168 G/T) and MMP-9 (-1562 C/T) promoter in oral submucous fibrosis and head and neck squamous cell carcinoma in an Indian population. Biomarkers (2011) 1.39

Prevalence of oral pre-malignant and malignant lesions at a tertiary level hospital in Allahabad, India. Asian Pac J Cancer Prev (2008) 1.35

Prevalence and molecular characterization of alpha-thalassemia syndromes among Indians. Genet Test (2008) 1.16

The use of an oral brush biopsy without computer-assisted analysis in the evaluation of oral lesions: a study of 94 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.16

Tuberculosis and immune thrombocytopenia. Haematologica (2002) 1.15

Thrombophilic dimension of Budd chiari syndrome and portal venous thrombosis--a concise review. Thromb Res (2010) 1.10

Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India. Clin Chim Acta (2009) 1.09

Regional heterogeneity of beta-thalassemia mutations in the multi ethnic Indian population. Blood Cells Mol Dis (2009) 1.08

Potential of commercial anti-D reagents in the identification of partial D variants in Indian population. Indian J Med Res (2007) 1.07

Global burden, distribution and prevention of β-thalassemias and hemoglobin E disorders. Expert Rev Hematol (2010) 1.06

Newborn screening shows a high incidence of sickle cell anemia in Central India. Hemoglobin (2012) 1.04

First-trimester prenatal diagnosis in haemophilia A and B families--10 years experience from a centre in India. Prenat Diagn (2006) 1.03

Glanzmann's thrombasthenia: updated. Platelets (2002) 1.03

Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India. Indian J Hum Genet (2010) 1.03

Prevalence of oral soft tissue lesions in Vidisha. BMC Res Notes (2010) 1.00

First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders. J Clin Pathol (2012) 0.99

Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss. Ann Intern Med (2015) 0.98

Lipid profile in oral submucous fibrosis. Lipids Health Dis (2009) 0.98

Strongyloides stercoralis septicaemia following steroid therapy for eosinophilia: report of three cases. Trans R Soc Trop Med Hyg (2007) 0.98

Osteoporosis in young haemophiliacs from western India. Am J Hematol (2007) 0.96

Contribution of natural anticoagulant and fibrinolytic factors in modulating the clinical severity of haemophilia patients. Br J Haematol (2007) 0.95

A simple diagnostic strategy for RhD typing in discrepant cases in the Indian population. Blood Transfus (2012) 0.95

Influence of CYP2C9 and VKORC1 gene polymorphisms on warfarin dosage, over anticoagulation and other adverse outcomes in Indian population. Eur J Pharmacol (2013) 0.94

Beta-globin gene cluster haplotypes linked to the betaS gene in western India. Hemoglobin (2004) 0.93

Cause of deep venous thrombosis and pulmonary embolism in young patients from India as compared with other ethnic groups. Blood Coagul Fibrinolysis (2012) 0.92

Congenital methemoglobinemia caused by Hb-MRatnagiri (beta-63CAT-->TAT, His-->Tyr) in an Indian family. Am J Hematol (2005) 0.92

Mutations in the MCFD2 gene and a novel mutation in the LMAN1 gene in Indian families with combined deficiency of factor V and VIII. Am J Hematol (2005) 0.92

Hereditary protein C deficiency in Indian patients with venous thrombosis. Ann Hematol (2012) 0.91

Anti-phospholipid antibodies and other immunological causes of recurrent foetal loss--a review of literature of various therapeutic protocols. Am J Reprod Immunol (2009) 0.91

Mannose binding lectin (MBL) in autoimmunity and its role in systemic lupus erythematosus (SLE). J Assoc Physicians India (2010) 0.91

Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study. J Clin Pathol (2010) 0.90

Morphometric analysis in potentially malignant head and neck lesions: oral submucous fibrosis. Asian Pac J Cancer Prev (2010) 0.90

Comparative study between the Hybrid Capture II test and PCR based assay for the detection of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J (2010) 0.89

Molecular diversity of hemoglobin H disease in India. Am J Clin Pathol (2010) 0.89

HLA A*02 allele frequencies and B haplotype associations in Western Indians. Hum Immunol (2003) 0.89

Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India. Thromb J (2007) 0.89

Immune-mediated thrombocytopenia following dactinomycin therapy in a child with alveolar rhabdomyosarcoma: the unresolved issues. J Pediatr Hematol Oncol (2004) 0.89

Paroxysmal nocturnal haemoglobinuria: diagnostic tests, advantages, & limitations. Eur J Haematol (2009) 0.88

Human platelet specific antigens and their importance. Indian Pediatr (2004) 0.88

Advances in autoimmune lymphoproliferative syndromes. Eur J Haematol (2011) 0.87

JAK2 mutations across a spectrum of venous thrombosis cases. Am J Clin Pathol (2010) 0.87

Sickle cell disease in India. Curr Opin Hematol (2014) 0.87

Tobacco use by Indian medical students and the need for comprehensive intervention strategies. Asian Pac J Cancer Prev (2010) 0.87

Splenic function in Omani children with sickle cell disease: correlation with severity index, hemoglobin phenotype, iron status, and alpha-thalassemia trait. Pediatr Hematol Oncol (2002) 0.85

Chromosomal breakage study in children suspected with Fanconi anemia in the Indian population. J Pediatr Hematol Oncol (2010) 0.85

Hb H disease due to homozygosity for a rare alpha2-globin variant, Hb Sallanches. Hemoglobin (2010) 0.85

An unusual presentation of pediatric acute lymphoblastic leukemia. Indian J Hematol Blood Transfus (2008) 0.85

Variable phenotypes of sickle cell disease in India with the Arab-Indian haplotype. Br J Haematol (2014) 0.85

Pathophysiology of acquired von Willebrand disease: a concise review. Eur J Haematol (2011) 0.85

Glucose-6-phosphate dehydrogenase (G6PD) deficiency among tribal populations of India - Country scenario. Indian J Med Res (2015) 0.85

Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation. J Allergy Clin Immunol (2012) 0.84

Letter: HLA B*1502 allele association with oxcarbamazepine-induced skin reactions in epilepsy patient from India. Epilepsia (2009) 0.84

Sickle cell disease in tribal populations in India. Indian J Med Res (2015) 0.84

Hemoglobin Fontainebleau [a21(B2)Ala>Pro]: The second report from India. Indian J Hum Genet (2013) 0.84

Elevated procoagulant endothelial and tissue factor expressing microparticles in women with recurrent pregnancy loss. PLoS One (2013) 0.83

Novel immunophenotypic and morphologic presentation in acute myeloid leukemia (AML) with JAK2 V617F mutation. Eur J Haematol (2009) 0.83

Identification of a novel large intragenic deletion in a family with Fanconi anemia: first molecular report from India and review of literature. Gene (2013) 0.83

Thrombophilic dimension of recurrent fetal loss in Indian patients. Blood Coagul Fibrinolysis (2008) 0.83

Correlation of addictive factors, human papilloma virus infection and histopathology of oral submucous fibrosis. J Oral Pathol Med (2010) 0.83

Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review. Eur J Haematol (2011) 0.83

Novel mutations in GP IIb gene in Glanzmann's thrombasthenia from India. Platelets (2009) 0.82

A common founder mutation p.P2063S in exon 36 of VWF in 11 unrelated Indian von Willebrand disease (VWD) families. Ann Hematol (2013) 0.82

Dandy-Walker malformations in a case of partial trisomy 9p (p12.1→pter) due to maternal translocation t(9;12)(p12.1;p13.3). Indian J Hum Genet (2007) 0.82

The spectrum of bleeding disorders in women with menorrhagia: a report from Western India. Ann Hematol (2004) 0.82

Defining the allelic variants of HLA A19 in the western Indian population. Hum Immunol (2002) 0.82

Dengue 2 virus inhibits in vitro megakaryocytic colony formation and induces apoptosis in thrombopoietin-inducible megakaryocytic differentiation from cord blood CD34+ cells. FEMS Immunol Med Microbiol (2008) 0.81

An atypical manifestation of acquired von Willebrand syndrome (AVWS) associated with systemic lupus erythematosus (SLE). Ann Hematol (2013) 0.81

Ex vivo expansion of umbilical cord blood stem cells using different combinations of cytokines and stromal cells. Acta Haematol (2007) 0.81

Neuropsychiatric manifestations and associated autoantibodies in systemic lupus erythematosus patients from Western India. Rheumatol Int (2014) 0.81

A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss. Eur J Obstet Gynecol Reprod Biol (2007) 0.81

Fc γ RIIA Genotypes and Its Association with Anti-C1q Autoantibodies in Lupus Nephritis (LN) Patients from Western India. Autoimmune Dis (2010) 0.80

Prenatal diagnosis of sickle syndromes in India: dilemmas in counselling. Prenat Diagn (2005) 0.80

Prenatal diagnosis in a family at risk for beta-thalassemia and hemophilia A: an uncommon association. Hemoglobin (2004) 0.80

Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. Indian J Dermatol Venereol Leprol (2010) 0.80

Sickle cell disease in India: A perspective. Indian J Med Res (2016) 0.80

Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases. J Clin Pharmacol (2009) 0.80

Von Willebrand factor 1 and factor 2 alleles (intron 40) are suitable markers for carrier detection in von Willebrand disease families in the Indian population. Acta Haematol (2006) 0.80

Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency among the tribals in Western India. Blood Cells Mol Dis (2009) 0.80

Comprehensive report of primary immunodeficiency disorders from a tertiary care center in India. J Clin Immunol (2012) 0.80

Mannose binding lectin (MBL) 2 gene polymorphism & its association with clinical manifestations in systemic lupus erythematosus (SLE) patients from western India. Indian J Med Res (2015) 0.79

Evaluation of the use of monoclonal antibodies and nested PCR for noninvasive prenatal diagnosis of hemoglobinopathies in India. Am J Clin Pathol (2008) 0.79

Spectrum of anti-neutrophil cytoplasmic antibodies in patients with pulmonary tuberculosis overlaps with that of Wegener's granulomatosis. Indian J Med Sci (2004) 0.79

Fc γ R IIB gene polymorphisms in Indian systemic lupus erythematosus (SLE) patients. Indian J Med Res (2011) 0.79

Imatinib resistance due to a novel tri-nucleotide insertion in the SH2/C lobe interface of BCR/ABL kinase domain between position K357 and N358. Leuk Res (2012) 0.79